Cell Line Development: Landscape and Future Market Evolution
Cross contamination and cell line misidentification are some of the major concerns associated with the use of cell lines. It has been estimated that a net loss of USD 28 billion is incurred every year on research that cannot be replicated due to the involvement of misidentified or contaminated cell lines in the US. To carry out cell line development and characterization, factors such as source of cell lines, their development history and the biological properties of cells determine the analytical tests required for characterization. The ‘Cell Line Development Services Market, 2017-2027’ report provides an extensive study on the current market landscape and future outlook of the cell line development and characterization service platform providers. Some of the most interesting insights from our study are presented below.
The US And EU Have Emerged As Key Service Hubs

Approximately 85% of the cell line development companies are located in North America and Europe; within Asia Pacific, Australia is one of the emerging hubs
The Landscape Of Services Providers Is Steadily Evolving
Currently, over 135 organizations globally offer cell line development and characterization services

Several Start-Ups And Small Companies Have Surfaced
Several start-ups and small companies have been established to cater to the growing demand for well characterized cell lines for a variety of application areas

Stakeholders Offer A Variety of Testing Services To Meet The Growing Demand
Identity testing is currently the most popular service offering; a large proportion of the companies provide services to characterize mammalian cell lines

Non-Industry Players Have Also Demonstrated A Strong Expertise
Majority of the academic players in this field offer cell line authentication services for a variety of cell types; STR profiling is the current gold standard for identity testing

We Expect Healthy Growth in the Long Term
Given the escalating requirements for cell lines in research, bioproduction and cell therapy manufacturing, the cell line development services market is projected to grow at a healthy rate

Non-Conventional Cell Lines, Though, Are Likely To Garner Relatively Higher Interest
In the foreseen future, significant revenues are likely to come from characterization services for non-conventional cell lines and growing operations in the Asia Pacific

To learn more, please click Cell Line Services Market, 2017-2027. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. You can also download the SAMPLE REPORT on cell line services by Roots Analysis.